oxybutynin has been researched along with Drug Withdrawal Symptoms in 9 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicotine dependence was assessed by the Fagerström Test for Nicotine Dependence (FTND) questionnaire, withdrawal symptoms by the Minnesota Nicotine Withdrawal Scale questionnaire and smoking cessation by self-reported abstinence at 1 week, 1 month and 6 months after treatment." | 6.75 | Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. ( Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J, 2010) |
| "Randomised controlled trials and meta-analyses have demonstrated that single therapy with either NRT, bupropion or varenicline are all more effective than placebo for smoking cessation." | 4.86 | Smoking cessation-recent advances. ( Ioannides-Demos, LL; McNeil, JJ; Piccenna, L, 2010) |
| "Nicotine dependence was assessed by the Fagerström Test for Nicotine Dependence (FTND) questionnaire, withdrawal symptoms by the Minnesota Nicotine Withdrawal Scale questionnaire and smoking cessation by self-reported abstinence at 1 week, 1 month and 6 months after treatment." | 2.75 | Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. ( Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mutlu, EA | 1 |
| Algate, DR | 1 |
| Beard, DJ | 1 |
| Prochaska, JJ | 1 |
| Fromont, SC | 1 |
| Ramo, DE | 1 |
| Young-Wolff, KC | 1 |
| Delucchi, K | 1 |
| Brown, RA | 1 |
| Hall, SM | 1 |
| Chowdhury, NA | 1 |
| Sewatsky, ML | 1 |
| Kim, H | 1 |
| McNeil, JJ | 1 |
| Piccenna, L | 1 |
| Ioannides-Demos, LL | 1 |
| De Ruyck, K | 1 |
| Nackaerts, K | 1 |
| Beels, L | 1 |
| Werbrouck, J | 1 |
| De Volder, A | 1 |
| Meysman, M | 1 |
| Salhi, B | 1 |
| Van Meerbeeck, J | 1 |
| Thierens, H | 1 |
| Simon, JA | 1 |
| Javitz, HS | 1 |
| Swan, GE | 1 |
| Lerman, C | 1 |
| Maathuis, MH | 1 |
| Dijkstra, DD | 1 |
1 review available for oxybutynin and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Smoking cessation-recent advances.
Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therap | 2010 |
3 trials available for oxybutynin and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Gender differences in a randomized controlled trial treating tobacco use among adolescents and young adults with mental health concerns.
Topics: Adolescent; Adolescent Health Services; Female; Gender Identity; Humans; Male; Mental Disorders; Men | 2015 |
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Catechol O-Methyltransferase; Double-Blind Method; Femal | 2010 |
The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.
Topics: Administration, Intranasal; Black People; Body Mass Index; Bupropion; Dopamine Uptake Inhibitors; Fe | 2011 |
5 other studies available for oxybutynin and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Oxybutynin dependence: a case presentation.
Topics: Adult; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Substance Withdrawa | 2011 |
The physical dependence liabilities of oxybutynin and morphine in rats.
Topics: Animals; Male; Mandelic Acids; Morphine; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; | 1985 |
Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Topics: Adolescent; Antiemetics; Botulinum Toxins, Type A; Cerebral Palsy; Delayed Diagnosis; Humans; Inject | 2017 |
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration S | 2011 |
Disaster after the plaster. Fentanyl withdrawal symptoms in a curable hospice patient.
Topics: Aged, 80 and over; Analgesics, Opioid; Colonic Neoplasms; Drug Administration Schedule; Female; Fent | 2011 |